Lataa...
Decreased Conversion of 25-hydroxyvitamin D(3) to 24,25-dihydroxyvitamin D(3) Following Cholecalciferol Therapy in Patients with CKD
BACKGROUND AND OBJECTIVES: Elevated concentrations of fibroblast growth factor 23 (FGF23) are postulated to promote 25-hydroxyvitamin D (25[OH]D) insufficiency in CKD by stimulating 24-hydroxylation of this metabolite, leading to its subsequent degradation; however, prospective human studies testing...
Tallennettuna:
| Julkaisussa: | Clin J Am Soc Nephrol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Nephrology
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4220759/ https://ncbi.nlm.nih.gov/pubmed/25183657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.03130314 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|